Partnering with a medical society

Tackling diagnostic delays in Duchenne Muscular Dystrophy (DMD)

The program reached over 85,000 neurologists, pediatricians, pediatric neurologists, internal medicine specialists, and family physicians.
A digital community developed across a series of groups dedicated to the discussion of rare neuromuscular diseases.
The DMD clinical case series garnered over 30,000 engagements from target healthcare professionals.

Educational Objectives

Reducing time to DMD diagnosis, which can be 2+ years.

Together with the expertise of the Muscular Dystrophy Association (MDA) and its members, we developed an educational program designed to improve participants' ability to identify possible DMD and refer for specialist investigation and diagnosis.

In addition, HCPs were engaged in discussions around optimal DMD management, multidisciplinary approaches, and emerging therapeutic options - including gene therapy and how this is different from conventional drug therapy.



Our Approach

Peer-to-peer learning

DMD experts were brought into discussion with multidisciplinary physicians less familiar with the rare condition, enabling peer-to-peer learning and sharing of real-world cases:

  • Neurologists
  • Pediatricians
  • Family physicians

Case-based education

MedShr fostered debate and discussion in a secure digital forum through case-based education tailored to specialists and generalists:

  • Digital forum to connect physicians across a range of clinical specialties and settings
  • Clinical case series with rising complexity
  • Nuances in clinical care decisions

MedShr's medical education programs are tailored, localized, and targeted

Case Studies: Targeted Medical Education 


Rare Disease:
Forum for Doctors

With rare diseases, medical education is critical to accelerating diagnosis and referral, and improving patient outcomes.
In this case-based medical education program, pediatricians, nephrologists, endocrinologists and family doctors came together in a digital case discussion forum to share their approaches to challenges in early detection of X-linked hypophospahtemia (XLH).


Pancreatic Cancer: Insights from KOLs

In pancreatic cancer and other rapidly evolving therapy areas, doctors are faced with an overwhelming amount of data. In this program, we connected oncologists, radiologists and hospitalists in a secure online forum on MedShr to reflect the cases they see in clinical practice. We then invited KOLs to share their insights about the implications of new data on diagnosis and management of patients.


Global Health:
900k HCPs reached 

Online medical education often fails to reach HCPs where it's needed most. With this ground-breaking program, we made a significant impact on patient care in LMICs, with over 903,400 doctors and community health workers engaging with  free, open-access, mobile-first education in malaria, sickle cell disease, leprosy, antimicrobial resistance, ophthalmology, HIV and other high burden conditions. 


MedShr's medical education programs deliver impact.

What would we recommend for your therapy area?